Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors
Condition:   Colorectal Cancer
Intervention:   Drug: M9140
Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 20, 2022Comments | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine